Clinical Trial Update: REGULUS: MRI-guided Adaptive SABR for Liver Cancers [Phase 2]

View source ↗

Summary

Stanford's REGULUS trial investigates MRI-guided adaptive SABR for liver cancers, including hepatocellular carcinoma and intrahepatic cholangiocarcinoma, curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Intrahepatic Cholangiocarcinoma
• Liver Metastases

Snippet

Sponsor: Stanford University | Conditions: Liver Cancer, Intrahepatic Cholangiocarcinoma | Phase 2 | Status: RECRUITING